Having said that, Elsohly developed the transmucosal patch as a successor to the suppository, so I have no idea why Nemus is developing the suppository at all. I've said it before, but I believe it's something they should abandon. A patch or even buccal pill would be significantly more lucrative.
News 
Market Data 
Discover 
